NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

白血球血球分離的全球市場:2020年∼2027年

Global Leukapheresis Market - 2020-2027

出版商 DataM Intelligence 商品編碼 1008539
出版日期 內容資訊 英文 180 Pages
商品交期: 約2個工作天內
價格
白血球血球分離的全球市場:2020年∼2027年 Global Leukapheresis Market - 2020-2027
出版日期: 2021年06月01日內容資訊: 英文 180 Pages
簡介

白細胞單採術是一種血液中白細胞數量減少的醫療程序,如果不及時治療,會導致癌症,例如血癌。全球白細胞單採市場的增長主要是由於白血病發病率增加、對 Leukopak 的需求增加以及更強大的給付政策。

本報告提供全球白血球血球分離市場相關調查分析,提供產業分析,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

目錄

第1章 全球白血球血球分離市場調查手法與調查範圍

第2章 全球白血球血球分離市場:市場定義與市場概要

第3章 全球白血球血球分離市場:摘要整理

第4章 全球白血球血球分離市場:市場動態

  • 影響市場的要素
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 影響分析

第5章 全球白血球血球分離市場:產業分析

  • 流行病學
  • 開發平台分析
  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 法規分析
  • 償付分析
  • 未滿足需求

第6章 全球白血球血球分離市場:COVID-19分析

  • COVID-19對市場的影響分析
  • COVID-19的價格趨勢
  • 需求與供給的頻譜
  • 政府在COVID-19疫情下的市場相關措施
  • 製造商策略性舉措
  • 結論

第7章 全球白血球血球分離市場:治療各類型

  • 簡介
  • 市場規模分析·與前一年同期比較成長率分析:治療各方法
  • 市場魅力指數:治療方法各市場區隔
    • 連續
    • 間歇

第8章 全球白血球血球分離市場:不同設備類型

  • 簡介
  • 市場規模分析·與前一年同期比較成長率分析:各設備
  • 市場魅力指數:設備各市場區隔
    • 血球分離設備
    • 白血球過濾器
    • 白血球管柱
    • 拋棄式
    • 其他

第9章 全球白血球血球分離市場:各用途

  • 簡介
  • 市場規模分析·與前一年同期比較成長率分析:各用途市場區隔
  • 市場魅力指數:各用途市場區隔
    • 治療
    • 研究

第10章 全球白血球血球分離市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 南美
  • 亞太地區
  • 中東·非洲

第11章 全球白血球血球分離市場:競爭情形

  • 競爭模式
  • 市場定位/佔有率分析
  • 合併和收購分析

第12章 全球白血球血球分離市場:企業簡介

  • Asahi Kasei Medical
  • Fresenius
  • Haemonetics Corporation
  • Terums BCT
  • STEMCELL Technologies
  • Macopharma
  • Hemacare
  • Allcells
  • Stemexpress
  • PPA research group等

第13章 全球白血球血球分離市場:重要考察

第14章 全球白血球血球分離市場:DataM

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Market Overview

The global leukapheresis market size was worth US$ XX billion in 2018 and is estimated to reach US$ XX billion by 2027, growing at a CAGR of XX % during the forecast period (2020-2027).

Leukapheresis is a medical procedure to reduce the high count of white blood cells in the blood, which, when left untreated, can cause cancer, primarily blood cancers. When there is an increase in the count of leukocytes (white blood cells), blood density increases, and so does the viscosity. These leukocytes interfere with pulmonary and cerebral blood flow and compete with tissues for oxygen. In such cases, the body won't be able to fight infections. Reason Leukemia patients are more prone to die due to infections. It is also performed to obtain white blood cells for later transplant, such as to treat a steep decrease in WBC counts during cancer chemotherapy. Another use is part of a novel form of immunotherapy, called chimeric antigen receptor (CAR) T-cell therapy, to help fight leukemia, prostate cancer, and other forms of cancers. Some signs and symptoms of leukemia are fatigue and weakness, bleeding from gums, trauma, bruising, fever, weight loss etc. The market is expected to drive in the future due to the high prevalence rate of leukemia cases.

Market Dynamics

The global leukapheresis market growth is driven by the growing incidence of Leukemia, increasing demand for Leukopaks, and growing polices on reimbursement are among the key factors driving market growth.

Increased incidence of leukemia, is expected to drive the global leukapheresis market during the forecast period.

Globally, the prevalence rate of leukemia has increased majorly. According to the National Cancer Institute (NIH), in 2017, an estimated 434,982 people lived with leukemia in the United States. It also estimates, the number of new leukemia cases has increased at an average rate of 0.3% each year over the last ten years (from 2006 to 2015) and may reach 60,530 in 2020.

According to the Leukemia & Lymphoma Society, leukemia was the sixth-most-common cause of cancer deaths globally from 2010 to 2015.

An increasing number of blood donations and surging demand for leukopaks are expected to drive the global Leukapheresis market.

As per the Centers For Drug Control and Prevention (CDC), In the US alone, every day, approximately 44,000 units of blood are required in hospitals and emergency treatment facilities, and there are more than 13.2 million blood donors. About 21 million units of blood components are transfused every year. The requirement of leukocytes/WBCs increases with the rise in demand for leukopaks in clinical research for developing CAR-T therapy for leukemia.

High treatment costs of treatment are likely to hinder the global leukapheresis market growth

In the next few years, the high cost of leukapheresis procedures and the shortage of trained doctors. For instance, with equipment priced at $50,000 or more per machine, Leukapheresis disposables costing between $1,500 and $3,000 per patient is likely to hamper the market growth.

Segment Analysis

Based on the device type, the global leukapheresis market is segmented into leukapheresis devices (apheresis device, leukapheresis columns and cell separators, leukoreduction filters), leukapheresis disposables

Based on device type, the global leukapheresis devices market is segmented into apheresis devices, leukapheresis columns & cell separators, and leukoreduction filters. In 2017, the apheresis devices segment accounted for the largest share of the Leukapheresis Devices Market. The high share of this segment is attributed to the widespread adoption of apheresis devices for performing therapeutic leukapheresis procedures to treat leukemia and the development of leukopaks for clinical and preclinical research.

Based on treatment method, the global leukapheresis market is segmented into continuous apheresis and intermittent apheresis

There are two ways in which leukapheresis can be performed. One being continuos apheresis (CFC) and other being intermittent apheresis (IFC). Of these two, continuous apheresis is the most commonly used method.

Continuous Apheresis involves the removal of blood through one venipuncture site and the return of blood through a separate venipuncture site.

In IFC, apheresis is conducted in disrupted cycles, including full blood removal, separation of necessary cells, and reinfusion of the remaining components. For removal, separation and reinfusion, CFC is an uninterrupted or persistent flow. Large extracellular volume (ECV), haemodynamic fluctuations and longer duration of the procedure are the key drawbacks of IFC, which is why CFC is proliferating method.

Based on application, the global leukapheresis market is segmented into therapeutic applications and research applications

The research applications segment is expected to drive for the largest share of the global leukapheresis products market in 2018 due to the growing adoption of leukapheresis products in research activities propelled by increasing research activities being undertaken for cancer, immunology, infectious diseases, drug discovery, regenerative medicine, and cell-based therapies.

Geographic Market Analysis

Asia -Pacific is the largest shareholder of the Leukapheresis market

The largest share of the market for leukapheresis products and leukopaks is projected to be in the Asia Pacific, followed by North America and Europe. The importance of APAC in this market is mainly due to the rise in the region's research in Regenerative Medicine, the increase in the number of clinical trials for CAR-T therapy, and leading pharmaceutical and biotech companies focused on cell therapy. Due to the advancement of healthcare infrastructure and services in the Asia Pacific, it is projected to see a high growth rate during the forecast period. Rising stem cell research will contribute positively to market growth in developing countries, such as India, Japan and China. The Japanese Ministry of Health, Labor, and Welfare approved the Regenerative Medicine Law in April 2013.

Global Leukapheresis Market Competitive Landscape

The global leukapheresis market has high competition among the key players like Asahi Kasei medical, Fresenius, Haemonetics Corporation, Terums BCT, STEMCELL Technologies, Macopharma, Hemacare, Allcells, Stemexpress, PPA research groups. The key players are adopting various growth strategies such as product launch, acquisitions and investments in multiple sectors. For instance, Fresenius Kabi purchased the biosimilars company from Merck KGaA in September 2017. In February 2019, Fresenius Medical Care acquired NxStage, a US-based manufacturer of in-home dialysis systems, for $2 billion.

Asahi Kasei Medical

Company overview- It is a Japanese multinational chemical corporation. Chemicals and materials science are the primary products. It was founded in May 1931, using Nobeoka Ammonia Fiber Co., Ltd, a Nobeoka, Miyazaki-based producer of ammonia, nitric acid, and other chemicals, as paid-in capital. It now has its headquarters in Tokyo, with offices and services in Japan, as well as in China, Singapore, Thailand, the United States and Germany.

Products overview- The company deals with production of healthcare devices like blood transfusion, bioprocess products like leukocyte reduction filters, virus removal filters etc.

Key developments

In 2019, Asahi Kasei acquired ViruSure. The company has completed its new spinning plant for Plannova filters.

Why Purchase the Report?

  • Visualize the composition of the global leukapheresis market analysis based on device type, treatment type, application and region highlighting the key commercial assets and players.
  • Identify commercial opportunities in global leukapheresis market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of global leukapheresis market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global leukapheresis market report would provide an access to an approx. 61 market data table, 50 figures and 300 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Table of Contents

1. Global Leukapheresis Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Leukapheresis Market - Market Definition and Overview

3. Global Leukapheresis Market - Executive Summary

  • 3.1. Market Snippet by Device Type
  • 3.2. Market snippet by Treatment Type
  • 3.3. Market Snippet by Application
  • 3.4. Market Snippet by Region

4. Global Leukapheresis Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increased cases of leukemia
      • 4.1.1.2. XX
    • 4.1.2. Restraints:
      • 4.1.2.1. Expensive treatment process
      • 4.1.2.2. XX
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Leukapheresis Market - Industry Analysis

  • 5.1. Epidemiology
  • 5.2. Pipeline Analysis
  • 5.3. Porter's Five Forces Analysis
  • 5.4. Supply Chain Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Reimbursement Analysis
  • 5.8. Unmet Needs

6. Global Leukapheresis Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Leukapheresis Market - By Treatment Type

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Method
  • 7.3. Market Attractiveness Index, By Treatment method Segment
    • 7.3.1. Continuous Apheresis*
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Intermittent Apheresis

8. Global Leukapheresis Market - By Device Type

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device
  • 8.3. Market Attractiveness Index, By Device Segment
    • 8.3.1. Apheresis machine*
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Leukocyte filters
    • 8.3.3. Leukocyte columns
    • 8.3.4. Disposables
    • 8.3.5. Others

9. Global Leukapheresis Market - By Application

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
  • 9.3. Market Attractiveness Index, By Application Segment
    • 9.3.1. Therapeutic*
      • 9.3.1.1. Introduction
      • 9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 9.3.2. Research

10. Global Leukapheresis Market - By Region

  • 10.1. Introduction
  • 10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 10.3. Market Attractiveness Index, By Region
  • 10.4. North America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
      • 10.4.6.1. U.S.
      • 10.4.6.2. Canada
      • 10.4.6.3. Mexico
  • 10.5. Europe
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Method
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. Germany
      • 10.5.6.2. U.K.
      • 10.5.6.3. France
      • 10.5.6.4. Italy
      • 10.5.6.5. Spain
      • 10.5.6.6. Rest of Europe
  • 10.6. South America
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Method
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.6.6.1. Brazil
      • 10.6.6.2. Argentina
      • 10.6.6.3. Rest of South America
  • 10.7. Asia Pacific
    • 10.7.1. Introduction
    • 10.7.2. Key Region-Specific Dynamics
    • 10.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Method
    • 10.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 10.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.7.6.1. China
      • 10.7.6.2. India
      • 10.7.6.3. Japan
      • 10.7.6.4. Australia
      • 10.7.6.5. Rest of Asia Pacific
  • 10.8. Middle East and Africa
    • 10.8.1. Introduction
    • 10.8.2. Key Region-Specific Dynamics
    • 10.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment method
    • 10.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 10.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

11. Global Leukapheresis Market - Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Global Leukapheresis Market- Company Profiles

  • 12.1. Asahi Kasei Medical*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Fresenius
  • 12.3. Haemonetics Corporation
  • 12.4. Terums BCT
  • 12.5. STEMCELL Technologies
  • 12.6. Macopharma
  • 12.7. Hemacare
  • 12.8. Allcells
  • 12.9. Stemexpress
  • 12.10. PPA research group

LIST NOT EXHAUSTIVE

13. Global Leukapheresis Market - Premium Insights

14. Global Leukapheresis Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us